These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7897635)
1. A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia. Ohashi Y; Tsuchiya S; Konno T J Med Genet; 1995 Jan; 32(1):77-8. PubMed ID: 7897635 [No Abstract] [Full Text] [Related]
2. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018 [TBL] [Abstract][Full Text] [Related]
3. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721 [No Abstract] [Full Text] [Related]
4. Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase. Vorechovský I; Luo L; de Saint Basile G; Hammarström L; Webster AD; Smith CI Hum Mol Genet; 1995 Dec; 4(12):2403-5. PubMed ID: 8634718 [No Abstract] [Full Text] [Related]
5. SSCP at the BTK locus. Vorechovský I Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224 [No Abstract] [Full Text] [Related]
6. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype. Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386 [TBL] [Abstract][Full Text] [Related]
7. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia. Schuster V; Seidenspinner S; Kreth HW Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128 [TBL] [Abstract][Full Text] [Related]
8. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA). Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420 [TBL] [Abstract][Full Text] [Related]
9. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269 [TBL] [Abstract][Full Text] [Related]
11. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900 [TBL] [Abstract][Full Text] [Related]
12. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hagemann TL; Chen Y; Rosen FS; Kwan SP Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320 [TBL] [Abstract][Full Text] [Related]
13. Maternal germinal mosaicism of X-linked agammaglobulinemia. Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495 [TBL] [Abstract][Full Text] [Related]
14. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA). Staehelin F; Kühne T Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406 [TBL] [Abstract][Full Text] [Related]
15. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families. Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824 [TBL] [Abstract][Full Text] [Related]
16. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697 [TBL] [Abstract][Full Text] [Related]
17. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734 [TBL] [Abstract][Full Text] [Related]
18. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. Saffran DC; Parolini O; Fitch-Hilgenberg ME; Rawlings DJ; Afar DE; Witte ON; Conley ME N Engl J Med; 1994 May; 330(21):1488-91. PubMed ID: 8164701 [No Abstract] [Full Text] [Related]
19. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Vihinen M; Nilsson L; Smith CI Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500 [TBL] [Abstract][Full Text] [Related]
20. Discordant phenotype in siblings with X-linked agammaglobulinemia. Bykowsky MJ; Haire RN; Ohta Y; Tang H; Sung SS; Veksler ES; Greene JM; Fu SM; Litman GW; Sullivan KE Am J Hum Genet; 1996 Mar; 58(3):477-83. PubMed ID: 8644706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]